The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

The ever-increasing use of GLP-1 agonists is uncovering clues about what else they can do. US doctors write billions of prescriptions each year. During 2024, though, one type of drug stood out ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...